Skip to content
PubMed This is a summary of 102 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 102 referenced papers

Top Authors

James D. Chalmers
University of Oxford
Stefano Aliberti
Humanitas University
Subash S. Heraganahally
Flinders University
Anne B. Chang
Queensland University of Technology
Miguel Ángel Martínez‐García
Hospital Universitari i Politècnic La Fe
Sanjay H. Chotirmall
Nanyang Technological University
Eva Polverino
Vall d'Hebron Institut de Recerca
Adam T. Hill
Edinburgh Royal Infirmary
Michael R. Loebinger
Royal Brompton Hospital
Francesco Blasi
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Top Institutions

Ranked by publications Top 10 institutions
06

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias

Madrid, Spain

147 papers

References

References (102)
  1. 1

    'Tree-in-bud': thinking beyond infectious causes.

    Terhalle E, Günther G

    Respiration; international review of thoracic diseases 2015; (89(2)):162-5 doi:10.1159/000370050.

    PMID: 25613822
  2. 2

    Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index.

    Minov J, Karadzinska-Bislimovska J, Vasilevska K, et al.

    The open respiratory medicine journal 2015; (9()):46-51 doi:10.2174/1874306401509010046.

    PMID: 25893025
  3. 3

    A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis.

    Finch S, McDonnell MJ, Abo-Leyah H, et al.

    Annals of the American Thoracic Society 2015; (12(11)):1602-11 doi:10.1513/AnnalsATS.201506-333OC.

    PMID: 26356317
  4. 4

    Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study.

    Ellis HC, Cowman S, Fernandes M, et al.

    The European respiratory journal 2016; (47(2)):482-9 doi:10.1183/13993003.01312-2015.

    PMID: 26585428
  5. 5

    The bronchiectasis severity index and FACED score for bronchiectasis.

    Guan WJ, Chen RC, Zhong NS

    The European respiratory journal 2016; (47(2)):382-4 doi:10.1183/13993003.01717-2015.

    PMID: 26828048
  6. 6

    Using Cystic Fibrosis Therapies for Non-Cystic Fibrosis Bronchiectasis.

    ElMaraachli W, Conrad DJ, Wang AC

    Clinics in chest medicine 2016; (37(1)):139-46.

    PMID: 26857775
  7. 7

    Dornase alfa for cystic fibrosis.

    Yang C, Chilvers M, Montgomery M, Nolan SJ

    The Cochrane database of systematic reviews 2016; (4()):CD001127 doi:10.1002/14651858.CD001127.pub3.

    PMID: 27043279
  8. 8

    Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.

    McDonnell MJ, Aliberti S, Goeminne PC, et al.

    Thorax 2016; (71(12)):1110-1118 doi:10.1136/thoraxjnl-2016-208481.

    PMID: 27516225
  9. 9

    Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.

    McDonnell MJ, Aliberti S, Goeminne PC, et al.

    The Lancet. Respiratory medicine 2016; (4(12)):969-979 doi:10.1016/S2213-2600(16)30320-4.

    PMID: 27864036
  10. 10

    Factors related to depression and anxiety in adults with bronchiectasis.

    Özgün Niksarlioglu EY, Özkan G, Günlüoğlu G, et al.

    Neuropsychiatric disease and treatment 2016; (12()):3005-3010 doi:10.2147/NDT.S121147.

    PMID: 27920537
  11. 11

    Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.

    Martinez-Garcia MA, Athanazio RA, Girón R, et al.

    International journal of chronic obstructive pulmonary disease 2017; (12()):275-284 doi:10.2147/COPD.S121943.

    PMID: 28182132
  12. 12

    Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.

    Maselli DJ, Amalakuhan B, Keyt H, Diaz AA

    International journal of clinical practice 2017; (71(2)) doi:10.1111/ijcp.12924.

    PMID: 28238229
  13. 13

    Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.

    Hill AT, Haworth CS, Aliberti S, et al.

    The European respiratory journal 2017; (49(6)) doi:10.1183/13993003.00051-2017.

    PMID: 28596426
  14. 14

    The computed tomographic "tree-in-bud" pattern: Characterization and comparison with radiographic and clinical findings in 36 cats.

    Hahn H, Specchi S, Masseau I, et al.

    Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 2018; (59(1)):32-42 doi:10.1111/vru.12564.

    PMID: 28994206
  15. 15

    Bronchial Artery Embolization for the Treatment of Acute Hemoptysis.

    Cody O'Dell M, Gill AE, Hawkins CM

    Techniques in vascular and interventional radiology 2017; (20(4)):263-265 doi:10.1053/j.tvir.2017.10.006.

    PMID: 29224659
  16. 16

    The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis.

    de la Rosa Carrillo D, Athanazio R, Girón Moreno RM, et al.

    ERJ open research 2018; (4(1)) doi:10.1183/23120541.00139-2017.

    PMID: 29531958
  17. 17

    Pulmonary hemangioma mimicking bronchiectasis: A case report.

    Li W, Xin T, Hu Y, et al.

    Medicine 2018; (97(25)):e11203 doi:10.1097/MD.0000000000011203.

    PMID: 29924044
  18. 18

    Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.

    Paredes Aller S, Quittner AL, Salathe MA, Schmid A

    Expert review of respiratory medicine 2018; (12(9)):769-782 doi:10.1080/17476348.2018.1503540.

    PMID: 30025482
  19. 19

    The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions.

    Polverino E, Dimakou K, Hurst J, et al.

    The European respiratory journal 2018; (52(3)) doi:10.1183/13993003.00328-2018.

    PMID: 30049739
  20. 20

    Management of bronchiectasis in adults.

    Visser SK, Bye P, Morgan L

    The Medical journal of Australia 2018; (209(4)):177-183 doi:10.5694/mja17.01195.

    PMID: 30107772
  21. 21

    Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis.

    O'Neill K, O'Donnell AE, Bradley JM

    Respirology (Carlton, Vic.) 2019; (24(3)):227-237 doi:10.1111/resp.13459.

    PMID: 30650472
  22. 22

    Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.

    Chalmers JD, Boersma W, Lonergan M, et al.

    The Lancet. Respiratory medicine 2019; (7(10)):845-854 doi:10.1016/S2213-2600(19)30191-2.

    PMID: 31405828
  23. 23

    Diagnostic imaging in adult 
non-cystic fibrosis bronchiectasis.

    Juliusson G, Gudmundsson G

    Breathe (Sheffield, England) 2019; (15(3)):190-197 doi:10.1183/20734735.0009-2019.

    PMID: 31508157
  24. 24

    Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis.

    Egan AM, Clain JM, Escalante P

    Journal of clinical tuberculosis and other mycobacterial diseases 2018; (10()):24-28 doi:10.1016/j.jctube.2017.12.003.

    PMID: 31720381
  25. 25

    The biology of pulmonary exacerbations in bronchiectasis.

    Amati F, Simonetta E, Gramegna A, et al.

    European respiratory review : an official journal of the European Respiratory Society 2019; (28(154)) doi:10.1183/16000617.0055-2019.

    PMID: 31748420
  26. 26

    Hot topics and current controversies in non-cystic fibrosis bronchiectasis.

    Severiche-Bueno D, Gamboa E, Reyes LF, Chotirmall SH

    Breathe (Sheffield, England) 2019; (15(4)):286-295 doi:10.1183/20734735.0261-2019.

    PMID: 31803263
  27. 27

    Effect of short-term inhalation of warm saline atomised gas on patients with non-cystic fibrosis bronchiectasis.

    Zhong L, Xiong Y, Zheng Z, et al.

    ERJ open research 2020; (6(1)) doi:10.1183/23120541.00130-2019.

    PMID: 32055629
  28. 28

    Noncystic Fibrosis Bronchiectasis: Evaluation of an Extensive Diagnostic Protocol in Determining Pediatric Lung Disease Etiology.

    Beckeringh NI, Rutjes NW, van Schuppen J, Kuijpers TW

    Pediatric allergy, immunology, and pulmonology 2019; (32(4)):155-162 doi:10.1089/ped.2019.1030.

    PMID: 32140286
  29. 29

    Non-CF bronchiectasis: Orphan disease no longer.

    Imam JS, Duarte AG

    Respiratory medicine 2020; (166()):105940 doi:10.1016/j.rmed.2020.105940.

    PMID: 32250872
  30. 30

    Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis.

    Martinez-García MA, Oscullo G, Posadas T, et al.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2021; (27(3)):428-434 doi:10.1016/j.cmi.2020.04.007.

    PMID: 32311472
  31. 31

    [Bronchiectasis - a review].

    Gudmundsson G, Juliusson G

    Laeknabladid 2020; (106(7)):352-361 doi:10.17992/lbl.2020.0708.592.

    PMID: 32608358
  32. 32

    Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis.

    Xu MJ, Dai B

    Therapeutic advances in respiratory disease 2020; (14()):1753466620936866 doi:10.1177/1753466620936866.

    PMID: 32615859
  33. 33

    Proteomics and Metabolomics for Cystic Fibrosis Research.

    Liessi N, Pedemonte N, Armirotti A, Braccia C

    International journal of molecular sciences 2020; (21(15)) doi:10.3390/ijms21155439.

    PMID: 32751630
  34. 34

    Bronchiectasis with secondary pulmonary infection in a child: A case report.

    Zhu T, Gu H, Vinturache A, et al.

    Medicine 2020; (99(39)):e22475 doi:10.1097/MD.0000000000022475.

    PMID: 32991486
  35. 35

    The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies.

    Xie B, Liu P, Wu Q, Xiang W

    The American journal of emergency medicine 2020; (38(12)):2713-2717 doi:10.1016/j.ajem.2020.08.042.

    PMID: 33046287
  36. 36

    Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis.

    He M, Zhu M, Wang C, et al.

    Bioscience reports 2020; (40(10)) doi:10.1042/BSR20194514.

    PMID: 33057706
  37. 37

    Asthma-Like Features and Anti-Asthmatic Drug Prescription in Children with Non-CF Bronchiectasis.

    Douros K, Sardeli O, Prountzos S, et al.

    Journal of clinical medicine 2020; (9(12)) doi:10.3390/jcm9124009.

    PMID: 33322440
  38. 38

    European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis.

    Chang AB, Fortescue R, Grimwood K, et al.

    The European respiratory journal 2021; (58(2)) doi:10.1183/13993003.02990-2020.

    PMID: 33542057
  39. 39

    Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study.

    Ameratunga R, Jordan A, Cavadino A, et al.

    Clinical and experimental immunology 2021; (204(3)):352-360 doi:10.1111/cei.13595.

    PMID: 33755987
  40. 40

    ERS International Congress 2020: highlights from the Paediatric Assembly.

    Ardura-Garcia C, Cuevas-Ocaña S, Freitag N, et al.

    ERJ open research 2021; (7(1)) doi:10.1183/23120541.00893-2020.

    PMID: 33778048
  41. 41

    Utility of Bronchiectasis severity index (BSI) as prognostic tool in patients with post tubercular bronchiectasis: An experience from a tertiary care hospital in North India.

    Deshmukh A, Vadala R, Talwar D

    The Indian journal of tuberculosis 2021; (68(2)):261-265 doi:10.1016/j.ijtb.2020.09.010.

    PMID: 33845962
  42. 42

    Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications.

    Kwok WC, Ho JCM, Tam TCC, et al.

    Respiratory research 2021; (22(1)):132 doi:10.1186/s12931-021-01729-5.

    PMID: 33910573
  43. 43

    [Multidisciplinary Management of Non-cystic-fibrosis Bronchiectasis - State of the Art].

    Mertsch P, Merhej H, Zardo P

    Zentralblatt fur Chirurgie 2021; (146(3)):346-358 doi:10.1055/a-1361-2252.

    PMID: 34154019
  44. 44

    Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort.

    Maselli DJ, Yen A, Wang W, et al.

    Radiology 2021; (300(3)):706-714 doi:10.1148/radiol.2021204052.

    PMID: 34156303
  45. 45

    Aspergillus-Associated Endophenotypes in Bronchiectasis.

    Jaggi TK, Ter SK, Mac Aogáin M, Chotirmall SH

    Seminars in respiratory and critical care medicine 2021; (42(4)):556-566 doi:10.1055/s-0041-1730947.

    PMID: 34261180
  46. 46

    Heterogeneity of non-cystic-fibrosis bronchiectasis in multiethnic Singapore: A prospective cohort study at a tertiary pulmonology centre.

    Young SL, Puan Y, Chew SY, et al.

    Annals of the Academy of Medicine, Singapore 2021; (50(7)):556-565 doi:10.47102/annals-acadmedsg.202178.

    PMID: 34342336
  47. 47

    Prevalence of depression and its associated factors in bronchiectasis: findings from KMBARC registry.

    Lee JH, Lee WY, Yong SJ, et al.

    BMC pulmonary medicine 2021; (21(1)):306 doi:10.1186/s12890-021-01675-4.

    PMID: 34579692
  48. 48

    Precision medicine in bronchiectasis.

    Pembridge T, Chalmers JD

    Breathe (Sheffield, England) 2021; (17(4)):210119 doi:10.1183/20734735.0119-2021.

    PMID: 35035573
  49. 49

    Influence of Comorbidities and Airway Clearance on Mortality and Outcomes of Patients With Severe Bronchiectasis Exacerbations in Taiwan.

    Huang HY, Chung FT, Lin CY, et al.

    Frontiers in medicine 2021; (8()):812775 doi:10.3389/fmed.2021.812775.

    PMID: 35127767
  50. 50

    Does the effect of comprehensive respiratory physiotherapy home-program differ in children with cystic fibrosis and non-cystic fibrosis bronchiectasis?

    Gurses HN, Ucgun H, Zeren M, et al.

    European journal of pediatrics 2022; (181(8)):2961-2970 doi:10.1007/s00431-022-04509-5.

    PMID: 35595860
  51. 51

    Exercise versus airway clearance techniques for people with cystic fibrosis.

    Heinz KD, Walsh A, Southern KW, et al.

    The Cochrane database of systematic reviews 2022; (6()):CD013285 doi:10.1002/14651858.CD013285.pub2.

    PMID: 35731672
  52. 52

    The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies.

    Li K, Liu L, Ou Y

    Journal of cardiothoracic surgery 2022; (17(1)):266 doi:10.1186/s13019-022-01882-y.

    PMID: 36221151
  53. 53

    Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review.

    Martínez-García MÁ, Oscullo G, García-Ortega A, et al.

    Drugs 2022; (82(14)):1453-1468 doi:10.1007/s40265-022-01785-1.

    PMID: 36264441
  54. 54

    Antibody deficiencies with normal IgG in adults with Non-cystic fibrosis bronchiectasis or recurrent pneumonia: Cross-sectional study.

    Zea-Vera AF, Chacón MA, Parra B

    Colombia medica (Cali, Colombia) 2022; (53(2)):e2014832 doi:10.25100/cm.v53i2.4832.

    PMID: 36415694
  55. 55

    The Effects of Respiratory Training Combined with Limb Exercise on Pulmonary Function and Quality of Life in Patients with Bronchiectasis.

    Ni R, Cai L, Xing Y, Fan X

    Journal of multidisciplinary healthcare 2023; (16()):475-482 doi:10.2147/JMDH.S388944.

    PMID: 36861133
  56. 56

    The BED-Pro Tool: facilitating the detection of bronchiectasis exacerbations.

    Gao YH, Guan WJ

    ERJ open research 2023; (9(3)) doi:10.1183/23120541.00087-2023.

    PMID: 37143843
  57. 57

    Advances in pharmacotherapy for bronchiectasis in adults.

    Zhang XX, Chen ZM, He ZF, Guan WJ

    Expert opinion on pharmacotherapy 2023; (24(9)):1075-1089 doi:10.1080/14656566.2023.2210763.

    PMID: 37161410
  58. 58

    Diagnostic delay in bronchiectasis: an Italian perspective.

    Chessari C, Simonetta E, Amati F, et al.

    ERJ open research 2024; (10(2)) doi:10.1183/23120541.00713-2023.

    PMID: 38500794
  59. 59

    Measuring accuracy of International Classification of Diseases codes in identification of patients with non-cystic fibrosis bronchiectasis.

    Green O, Liautaud S, Knee A, Modahl L

    ERJ open research 2024; (10(2)) doi:10.1183/23120541.00715-2023.

    PMID: 38500799
  60. 60

    Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.

    Bali V, Schelfhout J, Sher MR, et al.

    Therapeutic advances in respiratory disease 2024; (18()):17534666241236025 doi:10.1177/17534666241236025.

    PMID: 38501735
  61. 61

    Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).

    Spinou A, Hererro-Cortina B, Aliberti S, et al.

    The European respiratory journal 2024; (63(6)) doi:10.1183/13993003.01689-2023.

    PMID: 38609097
  62. 62

    Radiographic Outcomes in Pediatric Bronchiectasis and Factors Associated with Reversibility.

    Mills DR, Masters IB, Yerkovich ST, et al.

    American journal of respiratory and critical care medicine 2024; (210(1)):97-107 doi:10.1164/rccm.202402-0411OC.

    PMID: 38631023
  63. 63

    Pathophysiology of non-cystic fibrosis bronchiectasis in children and adolescents with asthma: A protocol for systematic review and meta-analysis.

    da Silva NC, Malagutti BC, Ladeira JMCD, et al.

    PloS one 2024; (19(4)):e0294921 doi:10.1371/journal.pone.0294921.

    PMID: 38635522
  64. 64

    Bronchiectasis management in adults: state of the art and future directions.

    Choi H, McShane PJ, Aliberti S, Chalmers JD

    The European respiratory journal 2024; (63(6)) doi:10.1183/13993003.00518-2024.

    PMID: 38782469
  65. 65

    Primary Ciliary Dyskinesia in Adult Bronchiectasis: Data from the German Bronchiectasis Registry PROGNOSIS.

    Ewen R, Pink I, Sutharsan S, et al.

    Chest 2024; (166(5)):938-950 doi:10.1016/j.chest.2024.05.023.

    PMID: 38880279
  66. 66

    Genetic background of pulmonary (vascular) diseases - how much is written in the codes?

    Eichstaedt CA, Haas SO, Shaukat M, Grünig E

    Current opinion in pulmonary medicine 2024; (30(5)):429-436 doi:10.1097/MCP.0000000000001090.

    PMID: 38913028
  67. 67

    Clinical Approach to Massive Hemoptysis: Perioperative Focus on Causes and Management.

    Toh TW, Goh JHF, Lie SA, et al.

    Journal of cardiothoracic and vascular anesthesia 2024; (38(10)):2412-2425 doi:10.1053/j.jvca.2024.06.002.

    PMID: 38964992
  68. 68

    Heterogeneity in non-cystic fibrosis bronchiectasis: insights from ASPEN trial participants.

    Ross MH, Jia S

    ERJ open research 2024; (10(4)) doi:10.1183/23120541.00372-2024.

    PMID: 39081500
  69. 69

    Current physiotherapy practice for adults with bronchiectasis: Data from the Australian bronchiectasis registry.

    Webb EM, Holland AE, Chang AB, et al.

    Respiratory medicine 2024; (233()):107777 doi:10.1016/j.rmed.2024.107777.

    PMID: 39181278
  70. 70

    Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management.

    Im Y, Chalmers JD, Choi H

    Tuberculosis and respiratory diseases 2025; (88(1)):109-119 doi:10.4046/trd.2024.0120.

    PMID: 39218441
  71. 71

    Targeting neutrophil serine proteases in bronchiectasis.

    Chalmers JD, Mall MA, Chotirmall SH, et al.

    The European respiratory journal 2025; (65(1)) doi:10.1183/13993003.01050-2024.

    PMID: 39467608
  72. 72

    [Management of adult bronchiectasis - Consensus-based Guidelines for the German Respiratory Society (DGP) e. V. (AWMF registration number 020-030)].

    Ringshausen FC, Baumann I, de Roux A, et al.

    Pneumologie (Stuttgart, Germany) 2024; (78(11)):833-899 doi:10.1055/a-2311-9450.

    PMID: 39515342
  73. 73

    Cough in non-cystic fibrosis bronchiectasis.

    Kantar A, Song WJ, Bush A, Chatziparasidis G

    ERJ open research 2024; (10(6)) doi:10.1183/23120541.00330-2024.

    PMID: 39624376
  74. 74

    Applicability and Validity of the "Bronchiectasis Severity Index" (BSI) and "FACED" Score in Adult Aboriginal Australians.

    Howarth T, Gibbs C, Abeyaratne A, Heraganahally SS

    International journal of chronic obstructive pulmonary disease 2024; (19()):2611-2628 doi:10.2147/COPD.S482848.

    PMID: 39650744
  75. 75

    The prevalence and implications of depression and anxiety in patients with bronchiectasis: a systematic review and meta-analysis.

    Chang MS, Kim HJ, Lee JH

    ERJ open research 2024; (10(6)) doi:10.1183/23120541.00248-2024.

    PMID: 39655172
  76. 76

    Non-cystic fibrosis bronchiectasis in pediatrics: A cohort profile of patients with inborn errors of immunity at a referral center in Cali, Colombia

    Murillo A, Marín D, Triviño J, et al.

    Biomedica : revista del Instituto Nacional de Salud 2024; (44(Sp. 2)):131-139 doi:10.7705/biomedica.7558.

    PMID: 39836842
  77. 77

    Infections, autoimmunity and immunodeficiencies are the leading etiologies of non-cystic fibrosis bronchiectasis in adults from the southwest of Colombia.

    Zea-Vera AF, Rodríguez CA, Giraldo S, et al.

    Biomedica : revista del Instituto Nacional de Salud 2024; (44(Sp. 2)):80-93 doi:10.7705/biomedica.7500.

    PMID: 39836848
  78. 78

    Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review.

    Tsouprou M, Koumpagioti D, Botsa E, et al.

    Antibiotics (Basel, Switzerland) 2025; (14(2)) doi:10.3390/antibiotics14020165.

    PMID: 40001409
  79. 79

    Non-Cystic Fibrosis Bronchiectasis in Adults: A Review.

    Barker AF, Karamooz E

    JAMA 2025; (334(3)):253-264 doi:10.1001/jama.2025.2680.

    PMID: 40293759
  80. 80

    Unveiling hidden culprits: new perspectives on bronchiectasis pathogens in Taiwan.

    Sombolestani A, Thornton CS

    ERJ open research 2025; (11(4)) doi:10.1183/23120541.00113-2025.

    PMID: 40661932
  81. 81

    Role of home-based pulmonary rehabilitation programs for disease progression and quality of life in patients with stable bronchiectasis: a single-center RCT.

    Min S, Liu H, Zhang Y, et al.

    Frontiers in medicine 2025; (12()):1571837 doi:10.3389/fmed.2025.1571837.

    PMID: 40740957
  82. 82

    Automated computed tomographic analysis of bronchial thickness and mucus plugs in bronchiectasis with asthma.

    van der Veer T, Andrinopoulou ER, Makani P, et al.

    ERJ open research 2025; (11(4)) doi:10.1183/23120541.00736-2024.

    PMID: 40761656
  83. 83

    Inhaled antibiotics and non-cystic fibrosis bronchiectasis: Trying to solve the puzzle.

    Ravi N

    Lung India : official organ of Indian Chest Society 2025; (42(5)):443-455 doi:10.4103/lungindia.lungindia_608_24.

    PMID: 40892817
  84. 84

    Potential Microorganisms from Bronchial Lavage Fluid in Bronchiectasis Patients: Bacteria, Nontuberculous Mycobacteria, and Fungi.

    Nguyen-Ho L, Tran-Le QK, Trinh HKT, et al.

    The open respiratory medicine journal 2025; (19()):e18743064392945 doi:10.2174/0118743064392945250613055623.

    PMID: 41036295
  85. 85

    Inflammatory Phenotypes of Bronchiectasis.

    Koukaki E, Papaiakovou G, Klironomou A, et al.

    Journal of personalized medicine 2025; (15(10)) doi:10.3390/jpm15100499.

    PMID: 41149860
  86. 86

    Lifei Qingchang Granules alleviate airway inflammation in a mouse model of bronchiectasis by inhibiting neutrophil extracellular traps.

    Yuanlong H, Wanyan L, Jiamin Z, et al.

    Journal of ethnopharmacology 2026; (356()):120855 doi:10.1016/j.jep.2025.120855.

    PMID: 41192693
  87. 87

    Bronchodilator response as an independent predictor of severity in bronchiectasis.

    Kang YR, Lee H, Choi H, et al.

    Journal of thoracic disease 2025; (17(10)):7515-7527 doi:10.21037/jtd-2025-713.

    PMID: 41229744
  88. 88

    Prevalence and incidence of adult bronchiectasis in Hong Kong from 2008-2023: A population-based cohort study.

    Yuan Z, Au PC, Cheung CL, et al.

    Respiratory medicine and research 2025; (88()):101220 doi:10.1016/j.resmer.2025.101220.

    PMID: 41237501
  89. 89

    Case Report: First pulmonary infection caused by Mycobacterium colombiense in a non-immunosuppressed host with bronchiectasis: diagnosis facilitated by synergistic mNGS and culture.

    Tan J, Liu L, Wang L, et al.

    Frontiers in medicine 2025; (12()):1671968 doi:10.3389/fmed.2025.1671968.

    PMID: 41244776
  90. 90

    Early Diagnosis of Non-Cystic Fibrosis Bronchiectasis in Childhood: Shedding Light on Barriers and Opportunities.

    Ghezzi M, Di Cicco M, Canali G, et al.

    Pediatric pulmonology 2025; (60(11)):e71365 doi:10.1002/ppul.71365.

    PMID: 41287460
  91. 91

    Long-Term Macrolides in Chronic Respiratory Diseases: Dusk or a New Dawn? A Narrative Review.

    Previtero D, Castelli G, Padrin Y, et al.

    Antibiotics (Basel, Switzerland) 2025; (14(11)) doi:10.3390/antibiotics14111061.

    PMID: 41301557
  92. 92

    Association between gastroesophageal reflux disease and incident bronchiectasis: a nationwide representative population-based study in Korea.

    Yoon J, Yoon JH, Lee H, et al.

    BMC pulmonary medicine 2025; (26(1)):7 doi:10.1186/s12890-025-04011-2.

    PMID: 41327280
  93. 93

    Prevalence of SERPINA1 mutations in a bronchiectasis cohort: implications of extended screening for alpha-1 antitrypsin deficiency.

    Sokoloski CS, Canan MGM, Leitão CA, Storrer KM

    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2025; (51(5)):e20250181 doi:10.36416/1806-3756/e20250181.

    PMID: 41370566
  94. 94

    Alpha-1 antitrypsin deficiency in bronchiectasis: Evidence for an overlooked entity beyond COPD: A retrospective observational study.

    Özdemir L, Pazarli AC, Gegin S, et al.

    Medicine 2026; (105(4)):e47298 doi:10.1097/MD.0000000000047298.

    PMID: 41578478
  95. 95

    New Perspectives in the Treatment of Bronchiectasis.

    Tramontano A, Caporaso M, Macciocchi G, et al.

    Archivos de bronconeumologia 2026; doi:10.1016/j.arbres.2025.12.008.

    PMID: 41617588
  96. 96

    Association of Chronic Rhinosinusitis and Pseudomonas Aeruginosa in Sputum of Patients With Non-Cystic Fibrosis Bronchiectasis.

    Grabauskas T, Brunton AE, Metersky ML, et al.

    Chronic obstructive pulmonary diseases (Miami, Fla.) 2026; (13(2)):158-166 doi:10.15326/jcopdf.2025.0732.

    PMID: 41738760
  97. 97

    Management of Adult Bronchiectasis: Consensus-Based Guidelines of the German Respiratory Society.

    Ringshausen FC, Baumann I, de Roux A, et al.

    Respiration; international review of thoracic diseases 2026; 1-73 doi:10.1159/000551643.

    PMID: 41861044
  98. 98

    Bronchiectasis in the precision medicine era: pathogenesis and therapeutic advances.

    Xia X, Wu Q, Cao Z, et al.

    Journal of thoracic disease 2026; (18(4)):411 doi:10.21037/jtd-2026-1-0207.

    PMID: 42182764
  99. 99

    Bronchiectasis in Older Adults: Distinctive Epidemiology, Etiology, Diagnosis, and Clinical Evolution Compared with Younger Populations.

    Cazzola M, Perrotta F, Pagliaro R, et al.

    Drugs & aging 2026; doi:10.1007/s40266-026-01322-9.

    PMID: 42474633
  100. 100

    Bronchiectasis in renal transplant patients: a narrative review.

    Dury S, Ancel J, Mulette P, et al.

    BMJ open respiratory research 2026; (13(1)) doi:10.1136/bmjresp-2026-004247.

    PMID: 42481411
  101. 101

    Nursing Roles and Responsibilities in Outpatient Bronchiectasis Care: A Scoping Review.

    Hiscock K, Jedwab RM

    Nursing reports (Pavia, Italy) 2026; (16(7)) doi:10.3390/nursrep16070242.

    PMID: 42506029
  102. 102

    Qualitative exploration assessing the acceptability of shared decision-making for prescribing airway clearance techniques in adults with bronchiectasis.

    McCallion P, Bradley J, Lally J, et al.

    BMJ open 2026; (16(7)):e119884 doi:10.1136/bmjopen-2026-119884.

    PMID: 42521311